Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Shares Outstanding of 1.33 billion shares for fiscal year 2024.
NORTHWEST BIOTHERAPEUTICS INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 1.33B | +13.0% |
| 2023 | 1.18B | +10.0% |
| 2022 | 1.07B | +12.7% |
| 2021 | 948.40M | +14.3% |
| 2020 | 829.60M | +35.0% |
| 2019 | 614.30M | +17.4% |
| 2018 | 523.20M | +59.1% |
| 2017 | 328.90M | +109.5% |
| 2016 | 157.00M | +63.8% |
| 2015 | 95.86M | +39.0% |
| 2014 | 68.96M | +51.0% |
| 2013 | 45.67M | +85.1% |
| 2012 | 24.68M | +164.4% |
| 2011 | 9.33M | -87.2% |
| 2010 | 73.12M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.52B | +18.0% | +4.1% |
| June 30, 2025 | 1.46B | +18.6% | +4.9% |
| March 31, 2025 | 1.39B | +16.4% | +4.7% |
| December 31, 2024 | 1.33B | +13.0% | +3.3% |
| September 30, 2024 | 1.29B | +12.3% | +4.6% |
| June 30, 2024 | 1.23B | +10.3% | +2.9% |
| March 31, 2024 | 1.20B | +10.4% | +1.7% |
| December 31, 2023 | 1.18B | +10.0% | +2.7% |
- NORTHWEST BIOTHERAPEUTICS INC showed an increase of +13.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2024 period, NORTHWEST BIOTHERAPEUTICS INC’s shares outstanding has grown by 1717.1% (from 73.12 million shares to 1.33 billion shares).
- The most recent figure is from NORTHWEST BIOTHERAPEUTICS INC’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: